Drugs / toltordine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03600766 Comparator | Aug 2018 → Jan 2020 | benign prostatic hyperplasia, erectile dysfunction, prostate neoplasm | Mansoura University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | toltordine | “oral toltordine 4 mg plus tamsulosin 0.4 mg daily for 8 weeks.” NCT03600766 ↗ |
| Route | Oral | “oral toltordine 4 mg plus tamsulosin 0.4 mg daily for 8 weeks.” NCT03600766 ↗ |